Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Sleep Apnea Monitor Recall Poses Logistic Challenges For Vital Signs

This article was originally published in The Gray Sheet

Executive Summary

Vital Signs should create a management plan to inform users how to monitor and correct settings for the firm's Breas AB CPAP PV10 sleep apnea ventilator, according to a UK Medical Device Alert

You may also be interested in...

Respironics Class I recall

Firm announces voluntary recall of 5,293 ComfortGel sleep apnea nasal masks distributed from Sept. 5-15 because some products were shipped without an exhalation port for carbon dioxide. Without the port, patients could experience oxygen deficiency or suffocation, the Murrysville, Penn. firm says Dec. 3. Respironics alerted FDA of the issue in September, and maintains that 82% of the recalled masks have returned with less than 3% affected. The company initiated a Class I recall for computer-controlled ventilators this summer (1"The Gray Sheet" July 7, 2003, In Brief)...

Celltrion Invests $450m Into Incheon Manufacturing Site

Celltrion has announced plans to add a third biopharmaceutical facility and a new global biotechnology research center at the Korean firm’s existing site in Songdo, Incheon, as the firm also revealed record third-quarter financial results.

Jefferies' Survey Predicts M&A Rebound In 2021

An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts